Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    CAN-004
Show Display Options
Rank Status Study
1 Recruiting Cvac as Maintenance Treatment in Patients With EOC in Complete Remission Following First-Line Chemotherapy or Second-Line Treatment
Condition: Epithelial Ovarian Cancer
Interventions: Biological: Placebo;   Biological: Cvac

Indicates status has not been verified in more than two years